Objective:
To determine whether home OCT guidance results in better visual acuity outcomes and/or a lower number of injections over 104 weeks compared to the traditional treat-and-extend approach for nAMD treatment, emphasizing the comparative effectiveness.
Key Findings:
- Home OCT may reduce treatment burden by allowing longer intervals between injections when patients are stable, which could enhance patient satisfaction.
- Earlier detection of disease activity through daily monitoring could lead to better visual outcomes, thereby improving overall patient care.
- Home OCT provides insights into fluid dynamics post-injection, enhancing treatment precision and informing clinical decisions.
Interpretation:
Home OCT has the potential to transform nAMD management by enabling timely interventions and personalized treatment plans, which could improve patient outcomes.
Limitations:
- Patient adherence to home OCT monitoring is crucial for effectiveness, as non-compliance could skew results.
- Integration of home OCT into busy clinical practices may present logistical challenges, including training and resource allocation.
Conclusion:
Home OCT could significantly enhance the management of nAMD, potentially leading to improved visual acuity and reduced treatment frequency, thereby transforming patient care in this field.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.